Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repolarization and Activation Mapping in Ventricular Tachycardia Ablation: the REDEMPTION Study

NCT06765746 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.

NCT NCT06765746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06765746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repolarization and Activation Mapping in Ventricular Tachycardia Ablation: the REDEMPTION Study
Lead sponsor
Universitair Ziekenhuis Brussel
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
June 1, 2027
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia ablation